Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 12/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 11/20 | 0.43 |
| ▸ | HPGD | P15428 | 11/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 11/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 7/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 6/20 | 0.43 |
| ▸ | TSHR | P16473 | 6/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.42 |
| ▸ | TOP2A | P11388 | 1/20 | 0.42 |
| ▸ | TLR7 | Q9NYK1 | 3/20 | 0.39 |
| ▸ | CASR | P41180 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6840149 | 0.85 | TOP2A (0.38) | ALDH1A1KDM4EHPGDHSD17B10CYP3A4 | |
| SCHEMBL6838145 | 0.85 | MTNR1A (0.39) | ALDH1A1KDM4EHPGDHSD17B10CYP3A4 | |
| SCHEMBL6837676 | 0.85 | EGFR (0.42) | ALDH1A1TSHRKMT2ATLR7CASR | |
| Fumaric Acid SCHEMBL6838681 | 0.81 | MTNR1A (0.37) | ALDH1A1KDM4EHPGDHSD17B10CYP3A4 | |
| Fumaric Acid SCHEMBL6838685 | 0.81 | MTNR1A (0.37) | ALDH1A1KDM4EHPGDHSD17B10CYP3A4 | |
| SCHEMBL6838095 | 0.80 | MTNR1A (0.50) | ALDH1A1KDM4ECYP3A4TSHRMEN1 | |
| SCHEMBL6833799 | 0.80 | TLR7 (0.46) | ALDH1A1TSHRTLR7CASRSMN1; SMN2 | |
| SCHEMBL6838642 | 0.78 | ALDH1A1 (0.45) | ALDH1A1KDM4EHPGDHSD17B10CYP3A4 | |
| SCHEMBL6838401 | 0.78 | MTNR1A (0.40) | ALDH1A1CYP3A4TLR7CASRSMN1; SMN2 | |
| SCHEMBL6833713 | 0.78 | NPY1R (0.39) | TLR7CASR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040054182-A1 | 1h-imidazopyridine derivatives | HOKURIKU SEIYAKU CO., LTD. (JP) | 2004-03-18 | — | — | US | disclosed |
| EP-1256582-A1 | 1H-IMIDAZOPYRIDINE DERIVATIVES | HOKURIKU SEIYAKU CO., LTD. (JP) | 2002-11-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040054182-A1 | 1h-imidazopyridine derivatives | IL2, IL1A, IL4 | ALDH1A1 504/4885KDM4E 2253/4885HPGD 394/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.